Page last updated: 2024-09-04

canertinib and Cancer of Colon

canertinib has been researched along with Cancer of Colon in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Brattain, MG; Foster, JM; Koterba, AP; Kreisberg, JI; Rajput, A; Willson, JK	1

Other Studies

1 other study(ies) available for canertinib and Cancer of Colon

Article	Year
A novel mechanism of resistance to epidermal growth factor receptor antagonism in vivo. Cancer research, 2007, Jan-15, Volume: 67, Issue:2 Topics: Animals; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Neoplasm; Enzyme Activation; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Humans; Immunohistochemistry; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Morpholines; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Signal Transduction; Transfection; Transforming Growth Factor alpha; Xenograft Model Antitumor Assays	2007

Article

Year

A novel mechanism of resistance to epidermal growth factor receptor antagonism in vivo.

Cancer research, 2007, Jan-15, Volume: 67, Issue:2

Topics: Animals; Apoptosis; Cell Growth Processes; Cell Line, Tumor; Colonic Neoplasms; Drug Resistance, Neoplasm; Enzyme Activation; ErbB Receptors; Extracellular Signal-Regulated MAP Kinases; Humans; Immunohistochemistry; MAP Kinase Signaling System; Mice; Mice, Inbred BALB C; Morpholines; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Receptor, ErbB-2; Signal Transduction; Transfection; Transforming Growth Factor alpha; Xenograft Model Antitumor Assays

2007